RPL43A Antibody

Shipped with Ice Packs
In Stock

Description

Biological Role of RPL43A

RPL43A is one of two yeast homologs (RPL43A and RPL43B) of the human ribosomal protein L43 (RPL43). These homologs share 90% DNA sequence identity and 100% amino acid sequence identity . Key functional attributes include:

  • Structural Localization: RPL43 is positioned near the peptidyl transferase center (PTC) of the ribosome, interacting with Rpl2 and contributing to 7S rRNA production .

  • Chaperone Interactions: RPL43 forms a trimeric complex with proteins Puf6 and Loc1, which regulate its loading onto the 60S subunit and influence mRNA localization .

Table 1: Comparative Features of Yeast RPL43 Homologs

FeatureRPL43ARPL43B
DNA Sequence Identity90%90%
Amino Acid Identity100%100%
Functional RoleRibosomal assembly, mRNA bindingRedundant with RPL43A

Antibody Development Challenges for RPL43A

  • Immunogen Design: Peptides derived from conserved regions (e.g., internal sequences of human RPL3) .

  • Validation: Western blot (WB), immunohistochemistry (IHC), and ELISA are standard validation methods .

  • Cross-Reactivity: Antibodies for ribosomal proteins often exhibit cross-species reactivity (e.g., human, mouse, rat) .

Research Applications of Ribosomal Protein Antibodies

Antibodies against ribosomal proteins like RPL3 serve as useful proxies for understanding RPL43A’s potential utility:

  • Mechanistic Studies:

    • RPL3 antibodies (e.g., Boster Bio A04311, Aviva OAAB09713) are used to study ribosome assembly defects .

    • Co-immunoprecipitation (Co-IP) techniques identify interaction partners (e.g., Puf6 and Loc1 with RPL43) .

  • Disease Associations:

    • Autoantibodies against ribosomal proteins are implicated in recurrent pregnancy loss (RPL) and cancer .

    • High-throughput platforms like reverse-phase protein arrays (RPPA) quantify ribosomal protein expression in cancer proteomics .

Key Considerations for Future RPL43A Antibody Development

  • Epitope Selection: Prioritize non-conserved regions to avoid cross-reactivity with RPL43B.

  • Functional Assays: Assess antibody performance in ribosome profiling or pre-60S subunit immunoprecipitation .

  • Clinical Relevance: Link RPL43A dysregulation to diseases (e.g., cancers, autoimmune disorders) using validated biomarkers .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
RPL43A antibody; YPR043W antibody; YP9499.02 antibody; 60S ribosomal protein L43-A antibody; L37a antibody; Large ribosomal subunit protein eL43-A antibody; YL35 antibody
Target Names
RPL43A
Uniprot No.

Target Background

Function
RPL43A is a component of the ribosome, a large ribonucleoprotein complex essential for protein synthesis within cells. The small ribosomal subunit (SSU) plays a crucial role in binding messenger RNAs (mRNAs) and translating the encoded genetic information by selecting appropriate aminoacyl-transfer RNA (tRNA) molecules. The large subunit (LSU) contains the ribosomal catalytic site known as the peptidyl transferase center (PTC). This site catalyzes the formation of peptide bonds, effectively polymerizing the amino acids delivered by tRNAs into a polypeptide chain. The newly synthesized polypeptides exit the ribosome through a tunnel in the LSU, where they interact with protein factors that facilitate enzymatic processing, targeting, and membrane insertion of nascent chains at the exit of the ribosomal tunnel.
Database Links

KEGG: sce:YJR094W-A

STRING: 4932.YPR043W

Protein Families
Eukaryotic ribosomal protein eL43 family
Subcellular Location
Cytoplasm.

Q&A

What is RPL43A and why is it significant in research?

RPL43A (Ribosomal Protein L43A) is a component of the 60S subunit of ribosomes, playing a critical role in protein synthesis. This ribosomal protein is highly conserved across species, indicating its evolutionary importance. Research interest in RPL43A has grown due to its potential involvement in various cellular processes beyond protein synthesis, including stress response mechanisms, cell growth regulation, and potential roles in certain pathological conditions. Like other ribosomal proteins such as RPL3, RPL43A may have extraribosomal functions that make it a valuable target for biological research.

What specimen types can be used with RPL43A antibodies?

RPL43A antibodies can be used with multiple specimen types including:

Specimen TypeCompatibilitySpecial Considerations
Cell linesHighOptimal for many human, mouse, and rat cell lines
Tissue sectionsGoodRequires optimization of fixation protocols
Tissue lysatesHighProtein extraction buffer selection is critical
Primary cellsGoodMay require adjustment of antibody concentration
Yeast cellsVariableSpecies-dependent cross-reactivity

When working with tissue samples, proper fixation is essential for preserving epitope accessibility. For tissues, paraformaldehyde fixation followed by paraffin embedding typically yields good results, similar to methods used with other ribosomal protein antibodies.

What are the recommended applications for RPL43A antibodies?

The primary applications for RPL43A antibodies include:

  • Western blotting (WB): Typically used at 1:500-2000 dilution

  • Immunohistochemistry (IHC): Effective at 1:50-400 dilution

  • Immunocytochemistry (ICC): Recommended at 1:50-400 dilution

  • Immunofluorescence (IF): Optimal at 1:50-400 dilution

  • Immunoprecipitation (IP): Effective at approximately 1:50 dilution

As with other ribosomal protein antibodies like RPL3, optimization of antibody concentration for each specific application and sample type is essential for obtaining reliable results.

What are the recommended storage conditions for RPL43A antibodies?

For optimal longevity and activity, store RPL43A antibodies according to these guidelines:

  • Long-term storage: -20°C to -70°C as supplied (typically stable for 12 months from date of receipt)

  • Short-term storage (1 month): 2-8°C under sterile conditions after reconstitution

  • Medium-term storage (6 months): -20°C to -70°C under sterile conditions after reconstitution

It is critical to avoid repeated freeze-thaw cycles, as this can significantly diminish antibody activity. Aliquoting the antibody upon first thaw is recommended for preservation of functionality. These storage recommendations align with those for other ribosomal protein antibodies such as RPL3.

What are the optimal blocking conditions for Western blots using RPL43A antibodies?

For Western blot applications with RPL43A antibodies, the following blocking protocol is recommended:

  • After transfer to a nitrocellulose or PVDF membrane, block with 5% non-fat milk in TBS for 1.5 hours at room temperature

  • Incubate with RPL43A antibody at 1:1000 dilution overnight at 4°C

  • Wash with TBS-0.1% Tween 3 times for 5 minutes each

  • Probe with an appropriate secondary antibody (typically anti-rabbit IgG-HRP) at 1:5000 dilution for 1.5 hours at room temperature

  • Develop using an ECL substrate system

This protocol has been shown to provide optimal signal-to-noise ratio for ribosomal proteins. Using a similar approach to that validated for RPL3 antibodies should yield reliable results.

How can I verify RPL43A antibody specificity?

To verify RPL43A antibody specificity, consider these approaches:

  • Positive controls: Use cell lines known to express RPL43A (most mammalian cell lines should work)

  • Negative controls: Include primary antibody omission controls

  • Knockout/knockdown validation: If available, compare wild-type samples with RPL43A knockout or knockdown samples

  • Peptide competition assay: Pre-incubate the antibody with excess immunizing peptide to confirm specific binding

  • Multiple antibody validation: Compare results using antibodies raised against different epitopes of RPL43A

The expected molecular weight for RPL43A is approximately 11-12 kDa; verification should include confirmation of detection at this size.

How should I design experiments to study RPL43A post-translational modifications?

When investigating post-translational modifications (PTMs) of RPL43A, consider this experimental approach:

  • Initial screening: Use phospho-specific or methyl-specific antibodies if available, or mass spectrometry to identify potential PTMs

  • Verification: Employ site-directed mutagenesis to confirm the specific modified residues

  • Functional analysis: Compare wild-type RPL43A with mutation-mimicking or mutation-preventing variants

  • Enzyme identification: Use inhibitors or knockout models of potential modifying enzymes to confirm the enzymatic pathway

Similar to studies on RPL42, where methylation at lysine residues was found to be functionally significant, RPL43A may undergo methylation that affects its function. Research on RPL42 demonstrated that methylation deficiency led to stress response defects, and similar approaches could be valuable for RPL43A investigation.

What are the best approaches for studying RPL43A interactions with other ribosomal components?

To study RPL43A interactions with other ribosomal components:

  • Co-immunoprecipitation (Co-IP): Use RPL43A antibodies to pull down the protein complex and identify interacting partners

  • Proximity ligation assay (PLA): Visualize and quantify protein-protein interactions in situ

  • Crosslinking mass spectrometry: Identify direct protein-protein contacts within the ribosome

  • Cryo-EM structural analysis: Determine the spatial relationship between RPL43A and other ribosomal components

  • Yeast two-hybrid or mammalian two-hybrid assays: Screen for potential interacting partners

When designing these experiments, consider using both intact ribosomes and ribosomal subunits to differentiate between direct and indirect interactions.

How can I effectively use RPL43A antibodies in stress response studies?

For studying RPL43A in stress response pathways:

  • Stress induction: Apply various stressors (oxidative stress, heat shock, nutrient deprivation) to cells

  • Temporal analysis: Track changes in RPL43A localization, expression, and modification at multiple time points

  • Subcellular fractionation: Determine if stress induces relocalization of RPL43A from ribosomes to other cellular compartments

  • Polysome profiling: Assess how stress affects RPL43A association with actively translating ribosomes

  • Comparison with known stress markers: Include well-characterized stress response proteins as controls

Research on related ribosomal proteins suggests that methylation can play important roles in stress adaptation, as demonstrated with RPL42, where methylation-deficient mutants showed higher sensitivity to stress conditions and defects in stress-responsive growth control.

What approaches can resolve contradictory results when studying RPL43A function?

When facing contradictory results in RPL43A research:

  • Validate antibody specificity: Ensure all antibodies used recognize the intended epitopes specifically

  • Compare experimental conditions: Systematically evaluate differences in cell types, stress conditions, or experimental methods

  • Account for redundancy: Consider functional overlap with other ribosomal proteins (e.g., RPL43B)

  • Assess extraribosomal functions: Determine if contradictions arise from non-canonical functions of RPL43A

  • Genetic background effects: Check for genetic modifiers that might influence phenotypes in different model systems

When designing these validation experiments, include appropriate controls and standardize protocols across different experimental setups to minimize technical variability.

How can RPL43A antibodies be used to investigate ribosome heterogeneity?

To investigate ribosome heterogeneity using RPL43A antibodies:

  • Sucrose gradient fractionation: Separate different ribosomal populations and analyze RPL43A distribution

  • Immunoaffinity purification: Isolate RPL43A-containing ribosomes and characterize their composition and associated mRNAs

  • Single-cell analysis: Use immunofluorescence to assess cell-to-cell variation in RPL43A incorporation into ribosomes

  • Tissue-specific analysis: Compare RPL43A-containing ribosomes across different tissues or developmental stages

  • Translation-specific ribosome profiling: Assess whether RPL43A is enriched in ribosomes translating specific mRNA subsets

This approach can provide insights into specialized ribosomes and their potential roles in regulating translation of specific mRNAs under different conditions.

What are the most effective methods for quantifying changes in RPL43A expression or modification levels?

For accurate quantification of RPL43A expression or modification:

  • Western blot with internal loading controls: Use housekeeping proteins or total protein staining (e.g., GAPDH, β-actin)

  • Quantitative real-time PCR: Measure RPL43A mRNA levels using validated reference genes

  • Mass spectrometry with isotope labeling: For precise quantification of protein abundance and modifications

  • ELISA: Develop sandwich ELISA for high-throughput quantification

  • Flow cytometry: For cell-by-cell quantification of RPL43A levels

When analyzing post-translational modifications, consider the ratio of modified to unmodified protein rather than absolute levels alone, as this provides insight into the regulatory dynamics.

How can RPL43A antibodies be utilized in ribosome quality control research?

For studying ribosome quality control mechanisms:

  • Co-localization with quality control factors: Assess RPL43A co-localization with factors like ZNF598, PELO, or HBS1L during stress

  • Ribophagy analysis: Examine RPL43A fate during selective autophagy of ribosomes

  • Ubiquitination pattern analysis: Determine if and how RPL43A is ubiquitinated during quality control processes

  • Ribosome collision detection: Use RPL43A antibodies alongside collision markers to study translation quality control

  • Split fluorescent protein complementation: Monitor real-time interactions between RPL43A and quality control machinery

These approaches can provide insights into how ribosomal proteins like RPL43A participate in or are targeted by quality control mechanisms that maintain translation fidelity.

What are the optimal approaches for studying RPL43A involvement in cellular aging processes?

To investigate RPL43A in aging processes:

  • Chronological aging models: Compare RPL43A expression, modification, and localization in young versus aged cells

  • Lifespan assays: Assess how RPL43A mutations affect cellular or organismal lifespan

  • Senescence marker correlation: Determine relationships between RPL43A status and established senescence markers

  • Stress resistance correlation: Evaluate how RPL43A modifications affect cellular resistance to age-related stressors

  • Translation fidelity assays: Measure how age-related changes in RPL43A affect ribosomal accuracy

Research on related ribosomal proteins has demonstrated connections to aging processes. For example, studies with RPL42 methylation-deficient mutants showed reduced ability to survive after entering stationary phase, suggesting a role in chronological aging.

How can advanced imaging techniques be combined with RPL43A antibodies for dynamic studies?

For dynamic imaging of RPL43A:

  • Super-resolution microscopy: Use techniques like STORM or PALM with RPL43A antibodies for nanoscale localization

  • Live-cell imaging: Combine with genetically encoded tags (if direct antibody use isn't feasible)

  • FRET/FLIM analysis: Study dynamic interactions between RPL43A and other proteins

  • Correlative light and electron microscopy (CLEM): Connect fluorescence localization with ultrastructural context

  • Lattice light-sheet microscopy: Observe RPL43A dynamics with minimal phototoxicity over extended periods

When designing these experiments, consider appropriate controls to confirm antibody specificity in imaging applications, as background can be problematic in advanced microscopy techniques.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.